Foamy virus vectors for suicide gene therapy

被引:0
|
作者
U Nestler
M Heinkelein
M Lücke
J Meixensberger
W Scheurlen
A Kretschmer
A Rethwilm
机构
[1] Institut für Virologie und Immunbiologie,
[2] Universität Würzburg,undefined
[3] Neurochirurgische Universitätsklinik,undefined
[4] Universitätskinderklinik,undefined
[5] Universität Würzburg,undefined
[6] Bayer AG,undefined
[7] Pharma-Research,undefined
[8] Kinderklinik des Universitätsklinikums der Stadt Mannheim,undefined
来源
Gene Therapy | 1997年 / 4卷
关键词
foamy virus vectors; suicide gene therapy; thymidine kinase; cytosine deaminase; polynucleoside phosphatase;
D O I
暂无
中图分类号
学科分类号
摘要
To improve the delivery of so-called suicide genes into tumors, recombinant retroviruses were constructed by inserting the herpes virus type 1 (HSV-1) thymidine kinase (tk), the E. coli cytosine deaminase (cd) and polynucleoside phosphorylase (pnp), or the jellyfish gene for the green fluorescent protein (gfp) into a foamy virus (FV)-derived replication-competent vector (pFOV-7). Expression and stability of the inserted foreign gene was analyzed by immunoblot and polymerase chain reaction (PCR). The functionality of the suicide genes was determined by a metabolic assay on virus vector infected cells and treatment with the respective prodrugs. In terms of vector stability and effectiveness of specific cell killing a virus transducing the pnp gene (FOV-7/pnp) was superior to those using the other two suicide genes. FOV-7/pnp is a candidate virus for suicide gene delivery into solid tumors.
引用
收藏
页码:1270 / 1277
页数:7
相关论文
共 50 条
  • [1] Foamy virus vectors for suicide gene therapy
    Nestler, U
    Heinkelein, M
    Lucke, M
    Meixensberger, J
    Scheurlen, W
    Kretschmer, A
    Rethwilm, A
    GENE THERAPY, 1997, 4 (11) : 1270 - 1277
  • [2] Foamy Virus Vectors for HIV Gene Therapy
    Olszko, Miles E.
    Trobridge, Grant D.
    VIRUSES-BASEL, 2013, 5 (10): : 2585 - 2600
  • [3] In-Vivo Gene Therapy with Foamy Virus Vectors
    Rajawat, Yogendra Singh
    Humbert, Olivier
    Kiem, Hans-Peter
    VIRUSES-BASEL, 2019, 11 (12):
  • [4] Lentivirus and foamy virus vectors: novel gene therapy tools
    Pandya, S
    Klimatcheva, E
    Planelles, V
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (01) : 17 - 40
  • [5] Gene therapy of Fabry disease - using foamy virus vectors
    Wiktorowicz, T.
    Rethwilm, A.
    HUMAN GENE THERAPY, 2011, 22 (10) : A109 - A109
  • [6] Gene transfer with foamy virus vectors
    Trobridge, G
    Vassilopoulos, G
    Josephson, N
    Russell, DW
    GENE THERAPY METHODS, 2002, 346 : 628 - 648
  • [7] Foamy virus vectors for gene transfer
    Trobridge, Grant D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (11) : 1427 - 1436
  • [8] Foamy virus vectors: new armaments for hematopoietic cell gene therapy
    Sorrentino, BP
    BLOOD, 2001, 98 (03) : 504 - 504
  • [9] Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides
    Weber, Conrad
    Armbruster, Nicole
    Scheller, Carsten
    Kreppel, Florian
    Kochanek, Stefan
    Rethwilm, Axel
    Steinert, Andre F.
    JOURNAL OF GENE MEDICINE, 2013, 15 (3-4): : 155 - 167
  • [10] Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replicationcompetent foamy virus vectors
    Heinkelein, M
    Hoffmann, U
    Lücke, M
    Imrich, H
    Müller, JG
    Meixensberger, J
    Westphahl, M
    Kretschmer, A
    Rethwilm, A
    CANCER GENE THERAPY, 2005, 12 (12) : 947 - 953